This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Stem cell therapy is a promising new technology that has the potential to revolutionize the way medical treatments are administered. Stem cells are a type of undifferentiated cell that has the ability to develop into specialized cells, such as those found in the blood, brain, heart, and other organs. By using stem cells, researchers are able to create new treatments for diseases and injuries that are currently untreatable. Stem cell therapy involves the use of stem cells to treat a variety of medical conditions. Stem cells can be harvested from the patient’s own body or from donated sources, such as umbilical cord blood. Once harvested, the stem cells are then manipulated in the laboratory in order to produce the desired cell types. The manipulated cells are then injected into the patient, where they can begin to repair damaged tissues and organs. In addition to replacing damaged cells, stem cell therapy has the potential to regenerate tissue and organs. This is accomplished by stimulating the natural growth of new cells and tissues in the body. This type of therapy has been used to treat a variety of conditions, including Parkinson's disease, Type 1 diabetes, spinal cord injuries, and others. Stem cell therapy is still in its early stages, and many of its potential applications have yet to be explored. However, the potential of this technology is immense, and researchers are working hard to unlock its full potential. As the technology advances, it could lead to the development of treatments and cures for a variety of diseases and injuries.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States